PERSONENI, NICOLA
PERSONENI, NICOLA
Dipartimento di Biotecnologie Mediche e Medicina Traslazionale
Derazantinib (ARQ 087) in advanced or inoperable FGFR2 gene fusion-positive intrahepatic cholangiocarcinoma.
2019 V. Mazzaferro, B. El-Rayes, M. Droz dit Busset, C. Cotsoglou, W. Harris, N. Damjanov, G. Masi, L. Rimassa, N. Personeni, F. Braiteh, V. Zagonel, K. Papadopoulos, T. Hall, Y. Wang, B. Schwartz, J. Kazakin, S. Bhoori, F. de Braud, W. Shaib
Tivantinib for second-line treatment of MET-high, advanced hepatocellular carcinoma (METIV-HCC): a final analysis of a phase 3, randomised, placebo-controlled study.
2018 L. Rimassa, E. Assenat, M. Peck-Radosavljevic, M. Pracht, V. Zagonel, P. Mathurin, E. Rota Caremoli, C. Porta, B. Daniele, L. Bolondi, V. Mazzaferro, W. Harris, N. Damjanov, D. Pastorelli, M. Reig, J. Knox, F. Negri, J. Trojan, C. López López, N. Personeni, T. Decaens, M. Dupuy, W. Sieghart, G. Abbadessa, B. Schwartz, M. Lamar, T. Goldberg, D. Shuster, A. Santoro, J. Bruix
Clinical results of stereotactic body radiotherapy (SBRT) in the treatment of isolated local recurrence of pancreatic cancer after R0 surgery : a retrospective study
2017 T. Comito, L. Cozzi, A. Zerbi, C. Franzese, E. Clerici, A. Tozzi, C. Iftode, P. Navarria, G. D'Agostino, A. Fogliata, P. Mancosu, S. Tomatis, C. Carnaghi, N. Personeni, A. Santoro, M. Scorsetti
Hepatocellular Carcinoma : A Global Disease in Need of Individualized Treatment Strategies
2017 N. Personeni, L. Rimassa
Can stereotactic body radiation therapy be a viable and efficient therapeutic option for unresectable locally advanced pancreatic adenocarcinoma? Results of a phase 2 study
2017 T. Comito, L. Cozzi, E. Clerici, C. Franzese, A. Tozzi, C. Iftode, P. Navarria, G. D'Agostino, L. Rimassa, C. Carnaghi, N. Personeni, M. Tronconi, F. De Rose, D. Franceschini, A. Ascolese, A. Fogliata, S. Tomatis, A. Santoro, A. Zerbi, M. Scorsetti
Prognostic value of the neutrophil-to-lymphocyte ratio in the ARQ 197-215 second-line study for advanced hepatocellular carcinoma
2017 N. Personeni, L. Giordano, G. Abbadessa, C. Porta, I. Borbath, B. Daniele, J. Van Laethem, H. Van Vlierberghe, J. Trojan, E.N. De Toni, A. Gasbarrini, M. Lencioni, M.E. Lamar, Y. Wang, D. Shuster, B. Schwartz, A. Santoro, L. Rimassa
Sorafenib in Hepatitis C Virus-Negative Patients With Hepatocellular Carcinoma: Don't Throw the Baby Out With the Bathwater!
2017 N. Personeni, R. L, G. L, S. A.
ARQ 087, an oral pan- fibroblast growth factor receptor (FGFR) inhibitor, in patients (pts) with advanced and/or metastatic intrahepatic cholangiocarcinoma (iCCA)
2016 V.M. Mazzaferro, W. Shaib, L. Rimassa, W. Harris, N. Personeni, B. El-rayes, A. Tolcher, T. Hall, Y. Wang, B. Schwartz, J. Kazakin, M. DROZ DIT BUSSET, C. Cotsoglou, K. Papadopoulos
KRAS mutation in lung metastases from colorectal cancer : Prognostic implications
2016 M. Ghidini, N. Personeni, S. Bozzarelli, M. Baretti, G. Basso, P. Bianchi, M.C. Tronconi, T. Pressiani, F. Grizzi, L. Giordano, A. Malesci, M. Alloisio, L. Laghi, A. Santoro, L. Rimassa
Tumor and circulating biomarkers in patients with second-line hepatocellular carcinoma from the randomized phase II study with tivantinib
2016 L. Rimassa, G. Abbadessa, N. Personeni, C. Porta, I. Borbath, B. Daniele, S. Salvagni, J. Van Laethem, H. Van Vlierberghe, J. Trojan, E.N. De Toni, A. Weiss, S. Miles, A. Gasbarrini, M. Lencioni, M.E. Lamar, Y. Wang, D. Shuster, B.E. Schwartz, A. Santoro
Assessment of HER2 status in patients with gastroesophageal adenocarcinoma treated with epirubicin-based chemotherapy: heterogeneity-related issues and prognostic implications
2016 N. Personeni, M. Baretti, S. Bozzarelli, P. Spaggiari, L. Rubino, M.C. Tronconi, U. Fumagalli Romario, R. Rosati, L. Giordano, M. Roncalli, A. Santoro, L. Rimassa
FOLFIRI and Cetuximab Every Second Week for First-Line Treatment of KRAS Wild-Type Metastatic Colorectal Cancer According to Phosphatase and Tensin Homolog Expression : a Phase II Study
2015 N. Personeni, L. Rimassa, C. Verusio, S. Barni, L. Rubino, S. Bozzarelli, E. Villa, C. Carnaghi, M.C. Tronconi, C. Gerardi, F. Galli, I. Floriani, A. Destro, C. Raschioni, R. Labianca, A. Santoro
A randomized, multicenter, phase II study of vandetanib monotherapy versus vandetanib in combination with gemcitabine versus gemcitabine plus placebo in subjects with advanced biliary tract cancer : the VanGogh study
2015 A. Santoro, V. Gebbia, T. Pressiani, A. Testa, N. Personeni, E. Arrivas Bajardi, P. Foa, A. Buonadonna, K. Bencardino, C. Barone, D. Ferrari, A. Zaniboni, M.C. Tronconi, G. Carteni, M. Milella, A. Comandone, S. Ferrari, L. Rimassa
Diagnostic accuracy of 11C-choline PET/CT in comparison with CT and/or MRI in patients with hepatocellular carcinoma
2015 E. Lopci, G. Torzilli, D. Poretti, L.J..S. de Neto, M.D. Donadon, L. Rimassa, E. Lanza, J.G. Sabongi, R. Ceriani, N. Personeni, A. Palmisano, V. Pedicini, T. Comito, M. Scorsetti, A. Chiti
Tivantinib for hepatocellular carcinoma
2015 L. Rimassa, N. Personeni, A. Santoro
Stereotactic Ablative Radiotherapy (SABR) in inoperable oligometastatic disease from colorectal cancer : a safe and effective approach
2014 T. Comito, L. Cozzi, E. Clerici, M.C. Campisi, R.L.E. Liardo, P. Navarria, A. Ascolese, A. Tozzi, C. Iftode, F. De Rose, E. Villa, N. Personeni, L. Rimassa, A. Santoro, A. Fogliata, P. Mancosu, S. Tomatis, M. Scorsetti
Tivantinib for second-line treatment of advanced hepatocellular carcinoma : a randomised, placebo-controlled phase 2 study
2013 A. Santoro, L. Rimassa, I. Borbath, B. Daniele, S. Salvagni, J..L. Van Laethem, H. Van Vlierberghe, J. Trojan, F..T. Kolligs, A. Weiss, S. Miles, A. Gasbarrini, M. Lencioni, L. Cicalese, M. Sherman, C. Gridelli, P. Buggisch, G. Gerken, R..M. Schmid, C. Boni, N. Personeni, Z. Hassoun, G. Abbadessa, B. Schwartz, R. Von Roemeling, M..E. Lamar, Y. Chen, C. Porta
Tivantinib : a new promising mesenchymal–epithelial transition factor inhibitor in the treatment of hepatocellular carcinoma
2013 L. Rimassa, N. Personeni, M. Simonelli, A. Santoro
Molecular determinants of outcome in sorafenib-treated patients with hepatocellular carcinoma
2013 N. Personeni, L. Rimassa, T. Pressiani, A. Destro, C. Ligorio, M.C. Tronconi, S. Bozzarelli, C. Carnaghi, L. Di Tommaso, L. Giordano, M. Roncalli, A. Santoro
The role of hepatic metastases and pulmonary tumor burden in predicting survival after complete pulmonary resection for colorectal cancer
2013 F. Sclafani, M. Incarbone, L. Rimassa, N. Personeni, L. Giordano, M. Alloisio, A. Santoro